跳至主要内容
临床试验/NCT03030560
NCT03030560已完成2 期

Effect of Intravenous Lidocaine Infusion on Long Term Postoperative Pain After Spinal Fusion Surgery

Abdelrady S Ibrahim, MD1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2015年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
numerical rating scale (NRS), pain score.

研究概览

简要总结

Spinal fusion is a painful surgery, and control of postoperative pain is difficult. Several studies have indicated that appropriate pain treatment protocols reduce postoperative morbidity, improve the results of the surgery, and decrease hospital costs

详细描述

Forty four patients were randomly allocated into two groups of equal size to receive either lidocaine infusion (Lidocaine group) or 0.9% sodium chloride infusion (Control group).

Randomization: was performed using Lidocaine group and Control group registers, which was placed in sealed envelopes prior to study initiation and opened prior to anesthesia by a physician who prepared the intravenous solution and identified it with the patient number, according to the envelope drawn. The solution was handed to another physician, blind to the prepared solutions' content, who was responsible for the anesthesia. The solution volume was equal. The responsible investigator was remained blind to the chosen group until the end of the study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Care Provider, Investigator)

盲法说明

Double Blind

入排标准

年龄范围
19 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years American Society of Anesthesiologists 1-3 status Patients undergoing spinal fusion or fixation

排除标准

  • Previous spinal fusion surgery.
  • Morbid obesity (BMI > 40)
  • Diagnosis of spinal metastatic cancer
  • Allergy to an amide local anesthetic or morphine sulfate
  • History of renal dysfunction, liver dysfunction or congestive heart failure
  • History of substance abuse disorder.
  • Chronic opioid use.

研究组 & 干预措施

Lidocaine group

Active Comparator

Patients will receive lidocaine infusion.

干预措施: Lidocaine (Drug)

Control group

Placebo Comparator

Patients will receive 0.9% Sodium-chloride infusion infusion

干预措施: 0.9% Sodium-chloride (Drug)

结局指标

主要结局

numerical rating scale (NRS), pain score.

时间窗: Postoperative 3 months

Postoperative numerical rating scale (NRS), pain score.

次要结局

  • opioid consumption.(Postoperative 24 h)
  • Serum cortisol.(Postoperative 24 h)

研究者

发起方
Abdelrady S Ibrahim, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Abdelrady S Ibrahim, MD

Assistant professor of anesthesia and ICU

Assiut University

研究点 (1)

Loading locations...

相似试验